🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will examine the safety and efficacy of pembrolizumab (MK-3475) ...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama ( Site 0023)
Start Date
2018-04-09
Trial ID
NCT03407144
This study is aimed to evaluate the efficacy and safety of sintilimab combi...
Status
Not Yet Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2023-12-15
Trial ID
NCT06152978
Treatments Being Tested
This study will assess the safety, tolerability, pharmacokinetics (PK), and...
Status
Completed
Location
Banner MD Anderson Cancer Center ( Site 0013)
Start Date
2017-07-02
Trial ID
NCT03179436
Treatments Being Tested
This is a Phase 1/2, first-in-human, open label, multicenter study to asses...
Status
Terminated
Location
Honor Health Research Institute
Start Date
2022-03-24
Trial ID
NCT05357898
Treatments Being Tested
This randomized clinical trial determining whether Sintilimab plus Capecita...
Status
Active Not Recruiting
Location
Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center
Start Date
2022-05-17
Trial ID
NCT05201859
Treatments Being Tested
Esophageal cancer is one of the most common malignancies, and concurrent ch...
Status
Completed
Location
The First Affiliated Hospital of Nanjing Medical University
Start Date
2022-01-01
Trial ID
NCT07015489
Treatments Being Tested
The purpose of this study is to determine if neoadjuvant (treatment before ...
Status
Recruiting
Location
Moffitt Cancer Center
Start Date
2024-05-17
Trial ID
NCT06295159
Treatments Being Tested
This is a randomized, phase II, multi-centre clinical trial. Sample size: ...
Status
Not Yet Recruiting
Location
Hospital General Universitario de Alicante
Start Date
2026-09-15
Trial ID
NCT07247786
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of allogen...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-01-24
Trial ID
NCT06212388
Treatments Being Tested
This is a multicenter, open-label, phase 2 study to evaluate the efficacy a...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-09-29
Trial ID
NCT03308942
Treatments Being Tested